A-Twin Tablet 40/5 mg

Adult dose

The recommended dosage is one tablet once daily, to be taken with water regardless of meals. It is advised to take it at the same time every day (for example, in the morning). In cases of severe renal impairment, treatment should be initiated at a lower dose, and the dose may be gradually increased. Patients with liver impairment should not exceed a daily dose of 40 mg of telmisartan. Elderly individuals (75 years and older) should be treated starting at a lower dose.

Child dose

The safety and efficacy of this medication have not been established in pediatric patients under the age of 18, so its use is not recommended.

This medication can cause serious harm to the fetus during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women or women who may become pregnant. This medication is contraindicated in patients with certain conditions. For example, patients with severely impaired liver or kidney function, hypotensive patients, or those with serious heart problems should not take this medication. Especially for nursing women, it is advisable to avoid taking this medication, and patients who are genetically hypersensitive to any component of this medication should also refrain from using it. Some patients may commonly experience side effects such as dizziness and edema, and more serious side effects can occur infrequently, so if abnormal symptoms arise during use, it is important to consult a doctor immediately. It is essential to regularly check blood pressure, kidney function, and electrolyte levels during the use of this medication to ensure there are no abnormalities. This medication may interact with other drugs, so if you are currently taking other medications, be sure to inform your doctor or pharmacist. Caution is needed when driving or operating dangerous machinery, as drowsiness or dizziness may occur. In the case of overdose, symptoms such as hypotension and heart problems may arise, thus requiring immediate medical attention at a healthcare facility. This medication is not recommended for children as its safety and efficacy have not been adequately established in this population.

Serious side effects

Urticaria, angioedema, Stevens-Johnson syndrome, exfoliative dermatitis, toxic epidermal necrolysis, thrombocytopenia, leukopenia, anaphylactic reaction, sepsis, hepatitis, jaundice, increased liver enzymes (with cholestasis), vasculitis, myocardial infarction, ventricular tachycardia, arrhythmia, atrial fibrillation, dyspnea, interstitial lung disease, renal impairment (including acute renal failure), syncope, severe hypotension, heart failure, cerebral infarction, congestive heart failure

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory tract infection
• pharyngitis
• sinusitis
• urinary tract infection
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia

This medication is sensitive to light, so it should be stored in a container that blocks light. It should also be kept at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.

Appearance

White or slightly off-white double convex oval tablet

Package unit

30 tablets (10 tablets/Alu-Alu) X 3